Orrick Advises Otsuka Pharmaceutical in Acquisition of Neurovance
King is a partner in the New York office and a member of the Global Mergers & Acquisitions and Private Equity Group. His practice focuses on domestic and cross-border M&A, joint venture, private equity and venture capital transactions, including negotiated mergers, auction bid processes, distressed asset sales, leveraged buyouts and the acquisition and divestiture of divisions and subsidiaries.
King is experienced in all aspects of Delaware and New York corporate, partnership and limited liability company law. He regularly counsels boards of directors on corporate governance, compliance, fiduciary duty and executive compensation matters.
King represents U.S. and non-U.S. clients in a wide range of industries, including life sciences, technology, energy, consumer products, industrials and manufacturing and financial services.
King’s recent transactions include representing: